ALFA Filings
Every announcement, straight from the exchange
Every Oxygenta Pharmaceutical other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements with these filters
The company filed its quarterly shareholding pattern as mandated under Regulation 31(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Oxygenta Pharmaceutical Limited has appointed M/s. PCR & Associates as its Cost Auditor for a 12-month term. This appointment follows the company's recent board meeting.
Oxygenta Pharmaceutical Ltd submitted its quarterly shareholding pattern for the period ended June 30, 2026, in compliance with SEBI regulatory requirements.